Seminars in Liver Disease

Papers
(The H4-Index of Seminars in Liver Disease is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma85
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD42
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns35
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?34
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype33
Genetic and Epigenetic Basis of Drug-Induced Liver Injury29
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease28
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease27
HBV Biomarkers and Their Role in Guiding Treatment Decisions27
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis23
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy21
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies20
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury19
Physiomimetic In Vitro Human Models for Viral Infection in the Liver18
Role of YAP1 Signaling in Biliary Development, Repair, and Disease17
Wilson Disease: Novel Diagnostic and Therapeutic Approaches16
Mice Engrafted with Human Liver Cells16
0.02261209487915